Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …

Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …

Background We aimed to evaluate the use of baricitinib, a Janus kinase (JAK) 1–2 inhibitor,
for the treatment of patients admitted to hospital with COVID-19. Methods This randomised …

Thromboembolism is a common and deadly consequence of COVID-19 infection for
hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and …

Platelet–endothelial interactions have a critical role in microcirculatory function, which
maintains tissue homeostasis. The subtle equilibrium between platelets and the vessel wall …

Background Paediatric multisystem inflammatory syndrome temporally associated with
SARS-CoV-2 (PIMS-TS), also known as multisystem inflammatory syndrome in children (MIS …

Introduction both symptomatic and asymptomatic SARS-CoV-2 infections–coined
Coronavirus disease 2019 (COVID-19)–have been linked to a higher risk of cardiovascular …

The COVID-19 pandemic has led to numerous negative implications for all aspects of
society. Although COVID-19 is a predominant lung disease, in 10–30% of cases, it is …

Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …

Background Hyperinflammation and coagulopathy are hallmarks of COVID-19 and
synergistically contribute to illness progression. Antiplatelet agents have been proposed as …